ConductScience.org, home

Paper16322467

The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.

Kertesz N and 6 others. Blood, 2006. Cited by 138 papers, by iCite.

Cite this record

ConductScience Library. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth. Papers, record 16322467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16322467

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
PubMed
Journal
Blood
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
138
iCite
Relative citation ratio, by iCite
2.65
iCite
Revised in PubMed
2024-11-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kertesz NNathalie
2Krasnoperov VValery
3Reddy RRamachandra
4Leshanski LLucy
5Kumar SRS Ram
6Zozulya SSergey
7Gill PSParkash S

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiogenesis Modulating AgentsMajor topic
Ephrin-B2Major topic
NeoplasmsMajor topic
Peptide FragmentsMajor topic
Receptor, EphB4Major topic
Angiogenesis Inhibitors
Animals
Cell Adhesion
Cell Line, Tumor
Cell Movement
Cell Proliferation
Cells, Cultured
Endothelium, Vascular
Growth Inhibitors
Humans
Mice
Neoplasms, Experimental
Neovascularization, Pathologic
Protein Binding
Solubility

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01CA79218NCI NIH HHSUnited StatesR01CA079218PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111972959Ephrins are not only unattractive.Trends Neurosci2002https://conductscience.org/library/papers/11972959PubMed
29685371Distinct subdomains of the EphA3 receptor mediate ligand binding and receptor dimerization.J Biol Chem1998https://conductscience.org/library/papers/9685371PubMed
37621826Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases.EMBO J1995https://conductscience.org/library/papers/7621826PubMed
410630644Growth factor signaling pathways in vascular development.Oncogene1999https://conductscience.org/library/papers/10630644PubMed
511754836The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function.Neuron2001https://conductscience.org/library/papers/11754836PubMed
611799227Neurobiology. Learning more about NMDA receptor regulation.Science2002https://conductscience.org/library/papers/11799227PubMed
78761303Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells.Oncogene1996https://conductscience.org/library/papers/8761303PubMed
89990854Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.Genes Dev1999https://conductscience.org/library/papers/9990854PubMed
911001067Vascular-specific growth factors and blood vessel formation.Nature2000https://conductscience.org/library/papers/11001067PubMed
1012594815Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF-C autocrine loops.Int J Cancer2003https://conductscience.org/library/papers/12594815PubMed
1111256076Multiple roles of EPH receptors and ephrins in neural development.Nat Rev Neurosci2001https://conductscience.org/library/papers/11256076PubMed
1210403252Eph receptors and ephrins restrict cell intermingling and communication.Nature1999https://conductscience.org/library/papers/10403252PubMed
1311163240The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration.Cell2001https://conductscience.org/library/papers/11163240PubMed
1410688823Vasculogenesis in the day 6.5 to 9.5 mouse embryo.Blood2000https://conductscience.org/library/papers/10688823PubMed
158689573Vasculogenesis.Annu Rev Cell Dev Biol1995https://conductscience.org/library/papers/8689573PubMed
1612134157EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).Nat Cell Biol2002https://conductscience.org/library/papers/12134157PubMed
1712185851Ephrins in reverse, park and drive.Trends Cell Biol2002https://conductscience.org/library/papers/12185851PubMed
1811750881The ephrins and Eph receptors in angiogenesis.Cytokine Growth Factor Rev2002https://conductscience.org/library/papers/11750881PubMed
1912118063Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis.J Cell Sci2002https://conductscience.org/library/papers/12118063PubMed
2010197531EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains.Neuron1999https://conductscience.org/library/papers/10197531PubMed

See all 45 referencesDownload CSV of references

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.

PMIDTitleJournalYearIn PapersSource
42698964Macrophages Drive Ferroptosis Resistance after Radiotherapy.Cancer Commun (Lond)2026https://conductscience.org/library/papers/42698964PubMed
41641748Prototyping Minimal Extracellular Vesicle Mimetics Using Cell-Free Synthesis.ACS Nano2026https://conductscience.org/library/papers/41641748PubMed
40044981EphB4-ephrin-B2 are targets in castration resistant prostate cancer.Br J Cancer2025https://conductscience.org/library/papers/40044981PubMed
39361504Overview of mechanism of electroacupuncture pretreatment for prevention and treatment of cardiovascular and cerebrovascular diseases.CNS Neurosci Ther2024https://conductscience.org/library/papers/39361504PubMed
38985143Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.Oncotarget2024https://conductscience.org/library/papers/38985143PubMed
38612645The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies.Int J Mol Sci2024https://conductscience.org/library/papers/38612645PubMed
38540132Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?Biomedicines2024https://conductscience.org/library/papers/38540132PubMed
38231476Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis.Cancer Res2024https://conductscience.org/library/papers/38231476PubMed
38097539Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression.Signal Transduct Target Ther2023https://conductscience.org/library/papers/38097539PubMed
37996538Eph receptors and ephrins in cancer progression.Nat Rev Cancer2024https://conductscience.org/library/papers/37996538PubMed
37982352Dihydroartemisinin inhibits melanoma migration and metastasis by affecting angiogenesis.Phytother Res2025https://conductscience.org/library/papers/37982352PubMed
37945764Progress in systemic therapy for advanced-stage urothelial carcinoma.Nat Rev Clin Oncol2024https://conductscience.org/library/papers/37945764PubMed
37823054Over-expression by degradation rescue of RTKs via cancer-secreted autocrine growth factors: a Phospho-degron-driven actionable layer of post-translational regulation?Front Oncol2023https://conductscience.org/library/papers/37823054PubMed
37575160EphrinB2: Expression of a novel potential target in renal cell carcinoma.Indian J Urol2023https://conductscience.org/library/papers/37575160PubMed
35725568EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment.Nat Commun2022https://conductscience.org/library/papers/35725568PubMed
34298619Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34298619PubMed
33816783Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma.Mol Ther Oncolytics2021https://conductscience.org/library/papers/33816783PubMed
33614496Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature.Front Oncol2020https://conductscience.org/library/papers/33614496PubMed
32488576The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.Mol Biol Rep2020https://conductscience.org/library/papers/32488576PubMed
32362422EphrinB2 expression in prostate adenocarcinoma: Implications for targeted therapy.Pathol Res Pract2020https://conductscience.org/library/papers/32362422PubMed

See all 77 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EPHB42050PubTator's text mininghttps://conductscience.org/library/genes/2050

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16322467

GET https://conductscience.org/api/papers/v1/16322467/references?page=2